-
DNAtrix, Valo Therapeutics Announce Partnership
americanpharmaceuticalreview
November 14, 2018
DNAtrix and Valo Therapeutics announced an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix's clinical stage viruses and Valo's proprietary antigenic peptide technology.
-
DNAtrix, Valo Therapeutics Announce Partnership
americanpharmaceuticalreview
November 14, 2018
DNAtrix and Valo Therapeutics announced an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix's clinical stage viruses and Valo's proprietary antigenic peptide technology.
-
Is Moderna prepping for biotech's biggest-ever IPO?
fiercebiotech
September 14, 2018
Modera Therapeutics is one of a select group of biotech "unicorns."
-
ImmusanT to develop Type 1 diabetes vaccine with JDRF backing
fiercebiotech
September 12, 2018
JDRF plans to do more than just support ImmusanT with a VC investment, and will engage in a collaboration on the project.
-
A Review of the Vaccines Marketed in China: 63 Varieties of Vaccines from 45 Enterprises
1℃
August 10, 2018
The vaccine incident of Changsheng Bio-technology has continued to simmer recently. Vaccine fabrication is something absolutely intolerable.
-
Online information on vaccines and autism not always reliable, study shows
worldpharmanews
June 20, 2018
Research at Brighton and Sussex Medical School (BSMS) has found that information available online can provide unreliable information based on old, 'weak' scientific studies. The study 'Fake news or weak science?' is published in open-access journal Fronti
-
Sanofi Pasteur and Translate Bio to develop new mRNA vaccines
pharmaceutical-technology
June 13, 2018
Global vaccine company Sanofi Pasteur has signed a research and development (R&D) collaboration and exclusive licensing agreement with therapeutics company Translate Bio to develop new vaccines using mRNA technology.
-
Sri Lanka to register two foreign cancer vaccines
biospectrumasia
June 08, 2018
The Russian vaccine ‘Hearticad’ which was brought down by the minister was rejected by the Sri Lanka College of Oncologists.
-
Roche's multiple sclerosis drug Ocrevus lowered patients' vaccine responses: study
fiercepharma
June 07, 2018
Roche’s multiple sclerosis newcomer Ocrevus was approved by the FDA last March bearing a warning about immunization.
-
Where is Pfizer putting its R&D hopes? Vaccines are front and center
fiercevaccines
May 17, 2018
On Pfizer’s first-quarter earnings call, CEO Ian Read drew up a long list of R&D programs the company’s expecting to drive future growth.